This inventor holds 42 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Breast Cancer Treatment. Top assignees: Medivation Technologies, Inc., Cytyc Health Corporation, Cytyc Corporation. Active years: 2001-2016.
Location History:
- Belmont, CA (US) (2001 - 2012)
- Redwood City, CA (US) (2009 - 2016)
Company Filing History:
19 out of 63 
9 out of 9 
6 out of 152 
Years Active: 2001-2016
Areas of Expertise:
Title: **David T Hung: Innovator in Pharmaceutical Compounds**
Introduction
David T Hung, based in Redwood City, CA, is a prolific inventor with a remarkable total of 42 patents to his name. His innovative contributions primarily focus on novel pharmaceutical compounds, offering significant potential for therapeutic applications.
Latest Patents
Among his latest patents are two notable inventions that pertain to the field of medicinal chemistry. The first patent discusses azepino[4,5-b]indoles and methods of use. This work introduces new azepino[4,5-b]indole compounds that have the capability to modulate a histamine receptor in individuals. The patent also describes novel compounds, including new 1,2,3,4,5,6-tetrahydroazepino[4,5-b]indoles, along with related pharmaceutical compositions.
The second patent involves pyrido[3,4-b]indoles and methods of use. This invention presents new heterocyclic compounds that may also modulate histamine receptors. The described compounds, under pharmaceutical compositions, are poised for various therapeutic applications, including the treatment of cognitive disorders, psychotic disorders, neurotransmitter-mediated disorders, and neuronal disorders.
Career Highlights
David T Hung has worked with leading companies in the biotech sector, notably Medivation Technologies, Inc. and Cytyc Health Corporation. His roles in these companies have significantly contributed to his extensive patent portfolio and have allowed him to push the boundaries of pharmaceutical innovations.
Collaborations
Throughout his career, David has collaborated with notable colleagues such as Andrew Asher Protter and Sarvajit Chakravarty. These partnerships have facilitated the exchange of ideas and expertise, enhancing the scope and impact of his work in the pharmaceutical industry.
Conclusion
David T Hung stands out as a trailblazer in the development of new medicinal compounds. His extensive patent portfolio and collaborative efforts showcase his dedication to advancing healthcare through innovative discoveries. With ongoing contributions to the field, his work continues to inspire future advancements in pharmaceuticals.